News from abbott A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

May 24, 2022, 17:11 ET Abbott to Release EleCare® Amino Acid-based Formulas to Help Meet Critical Patient Need

Abbott (NYSE: ABT) today announced that the U.S. District Court for the Western District of Michigan has amended the recent consent decree allowing...

May 19, 2022, 09:15 ET New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies

Data presented at EuroPCR 2022 reinforce the impact of Abbott's minimally invasive heart devices on patient outcomes and quality of life Findings...

May 16, 2022, 16:22 ET Abbott Enters into Consent Decree with U.S. Food and Drug Administration for its Sturgis, Mich., Plant; Agreement Creates Pathway to Reopen Facility

Abbott (NYSE: ABT) has agreed to enter into a consent decree with the U.S. Food and Drug Administration (FDA) related to its Sturgis, Mich., infant...

May 11, 2022, 09:00 ET Abbott and Women as One Partner to Help More Underrepresented Physicians Lead Clinical Trials

Abbott (NYSE: ABT) today announced a new partnership with Women as One to launch a new program designed to train more female and underrepresented...

May 04, 2022, 09:00 ET Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise

Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity™ m system, which provides fast results in high volumes –...

Apr 29, 2022, 16:35 ET Abbott to Release Metabolic Nutrition Formulas

At the request of the U.S. Food and Drug Administration (FDA), Abbott (NYSE: ABT) is releasing limited quantities of metabolic nutrition formulas...

Apr 29, 2022, 09:00 ET Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months

Abbott (NYSE: ABT) today announced results from the PERSIST-END study, which showed that nearly nine out of 10 patients (89%) treated for persistent...

Apr 28, 2022, 09:00 ET Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer™ Steerable Delivery Sheath for the Company's Amulet™ Device

Abbott (NYSE: ABT) today announced U.S. availability of its Amplatzer™ Steerable Delivery Sheath, which is used with the company's Amplatzer Amulet™...

Apr 28, 2022, 07:00 ET New Analysis Shows that Abbott's FreeStyle Libre® System Provides Similar and Sustained Reductions in Glucose Levels for People with Both Type 1 and Type 2 Diabetes

Meta-analysis of 75 real-world studies found that Abbott's FreeStyle Libre system is associated with significant reductions in glycated hemoglobin...

Apr 27, 2022, 08:00 ET Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes

Abbott (NYSE: ABT), CamDiab and Ypsomed today announced that they are partnering to develop and commercialize an integrated automated insulin...

Apr 26, 2022, 09:00 ET Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment Corporation

Abbott (NYSE: ABT) received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation (TRC) to purchase up to 1,000,000 Abbott ...

Apr 25, 2022, 09:00 ET Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere™ myPath™ Digital Health App

Abbott (NYSE: ABT) today announced that it has launched an upgraded version of its NeuroSphere™ myPath™ digital health app with enhanced...

Apr 20, 2022, 07:30 ET Abbott Reports First-Quarter 2022 Results

...

Apr 04, 2022, 09:00 ET Abbott Receives FDA Approval for Aveir™ VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms

Abbott's Aveir single chamber (VR) pacing system is the world's only leadless pacemaker with a unique mapping capability to assess correct...

Mar 30, 2022, 07:30 ET Abbott and LISC Team Up to Address Diversity and Equity Gaps in the Healthcare Industry Supply Chain

Abbott (NYSE: ABT) and the Local Initiatives Support Corporation (LISC) announced a $37.5 million initiative to provide diverse small businesses with ...

Mar 28, 2022, 09:00 ET Abbott Hosts Conference Call for First-Quarter Earnings

Abbott (NYSE: ABT) will announce its first-quarter 2022 financial results on Wednesday, April 20, 2022, before the market opens. The announcement...

Mar 24, 2022, 09:00 ET Abbott's FreeStyle® Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin

Abbott (NYSE: ABT) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the expansion of reimbursement coverage for...

Feb 18, 2022, 11:26 ET Abbott Declares 393rd Consecutive Quarterly Dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 47 cents per share. Abbott has increased its dividend...

Feb 17, 2022, 17:11 ET Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant

Abbott (NYSE: ABT) is initiating a proactive, voluntary recall of powder formulas, including Similac, Alimentum and EleCare manufactured in Sturgis,...

Feb 07, 2022, 09:00 ET Abbott Announces World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial

Abbott (NYSE: ABT) today announced the world's first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i™...

Jan 26, 2022, 07:30 ET Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast

Abbott (NYSE: ABT) today announced financial results for the fourth quarter and full year ended Dec. 31, 2021, and issued its financial outlook for...

Jan 12, 2022, 09:00 ET Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms

Abbott (NYSE: ABT) today announced it has received clearance from the U.S. Food and Drug Administration for the EnSite™ X EP System with EnSite...

Jan 06, 2022, 13:24 ET Abbott anuncia o Futuro dos Biowearables no CES (Consumer Electronics Show)

Jan 06, 2022, 13:23 ET Abbott anuncia el futuro de los biowearables en el evento CES (Consumer Electronics Show) de Las Vegas